跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADIRAMEDICAVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ADIRAMEDICAVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle
Approved
STANDARD
ADIRAMEDICAVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle
AdiraMedica Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
feda1ce9f740a882
Company
AdiraMedica Pty Ltd
Type
Standard
Approval Details
Approval Id
feda1ce9f740a882
Product Name
ADIRAMEDICAVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle
Artg Id
407838
Artg Name
ADIRAMEDICAVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle
Sponsor
AdiraMedica Pty Ltd
Company Detail Path
/organization/adiramedica-pty-ltd
Artg Date
2025-03-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
feda1ce9f740a882
Type
Standard
Back to TGA Approvals